Regardless of the mechanisms involved in AKT-dependent activation of NF-κB in TMZ-treated cells, our results show that this molecular event has a pro-survival function in tumor cells presenting constitutive activation of the MAPK and/or PI3K/AKT signaling pathways. The gene discussed is PIK3CA; the disease is neoplasm.